Even After Rising 29% This Past Week, Seres Therapeutics (NASDAQ:MCRB) Shareholders Are Still Down 84% Over the Past Three Years

Yahoo FinanceJul 19 07:56 ET

Great Week for Seres Therapeutics, Inc. (NASDAQ:MCRB) Institutional Investors After Losing 69% Over the Previous Year

Simply Wall StJul 18 14:19 ET

Market Chatter: Huawei Sells Interests in Aito to Seres Group

MT NewswiresJul 4 02:03 ET

Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity Under Strategic Partnership With Pfizer

PR NewswireJun 12 07:00 ET

12 Health Care Stocks Moving In Monday's Intraday Session

BenzingaJun 10 12:31 ET

Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session

BenzingaJun 7 13:07 ET